Authors
Loading...
Randomized trial evaluates blood factor binding in adenovirus variants, suggesting new targeting strategies.
Olivia et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: